• Home
  • Allosteric SHP2 inhibitors in cancer: Targeting the intersection of RAS, resistance, and the immune microenvironment.

Allosteric SHP2 inhibitors in cancer: Targeting the intersection of RAS, resistance, and the immune microenvironment.

Author List
Kerr DL, Haderk F, Bivona TG
Publication
Current opinion in chemical biology
Publication ID (Profile URL)
https://researcherprofiles.org/profile/165308348
Publication Year
2021
PubMed ID
33418513
Publication Title
Kerr DL, Haderk F, Bivona TG. Allosteric SHP2 inhibitors in cancer: Targeting the intersection of RAS, resistance, and the immune microenvironment. Curr Opin Chem Biol. 2021 06; 62:1-12.